SCHEMBL678618

SCHEMBL678618

Nc1ccc(NC(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.81
MEN1 O00255 3/20 0.81
POLB P06746 2/20 0.81
LMNA P02545 2/20 0.81
TDP1 Q9NUW8 2/20 0.81
PKM P14618 1/20 0.81
APEX1 P27695 1/20 0.81
PRMT1 Q99873 1/20 0.79
NPC1 O15118 3/20 0.65
RAB9A P51151 3/20 0.65
PTGS1 P23219 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
NT5E P21589 1/20 0.64
MAPK1 P28482 1/20 0.64
CA12 O43570 1/20 0.63
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
CA9 Q16790 1/20 0.63
MAPT P10636 1/20 0.61
KCNQ3 O43525 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL684089 1.00 KMT2A (0.81) KMT2AMEN1POLBLMNATDP1
SCHEMBL9681496 0.90 POLB (1.00) KMT2AMEN1POLBLMNATDP1
SCHEMBL1353478 0.90 POLB (1.00) KMT2AMEN1POLBLMNATDP1
SCHEMBL137276 0.90 POLB (1.00) KMT2AMEN1POLBLMNATDP1
SCHEMBL2128727 0.90 POLB (1.00) KMT2AMEN1POLBLMNATDP1
SCHEMBL30319980 0.90 POLB (1.00) KMT2AMEN1POLBLMNATDP1
SCHEMBL9767723 0.90 NPC1 (0.76) KMT2AMEN1POLBLMNATDP1
SCHEMBL10939703 0.90 NPC1 (0.76) KMT2AMEN1POLBLMNATDP1
SCHEMBL611657 0.90 NPC1 (0.76) KMT2AMEN1POLBLMNATDP1
SCHEMBL8442129 0.88 POLB (0.96) KMT2AMEN1POLBLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269758-A1 NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS MERCK PATENT GMBH (DE) 2011-11-03 US claimed
JP-2011526912-A 2011-10-20 JP claimed
EP-2291376-A2 NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS Merck Patent GmbH (DE) 2011-03-09 EP claimed
WO-2010002779-A2 NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS MERCK SERONO S.A. (CH) 2010-01-07 WO claimed
CN-112851538-B Method for promoting acylation of amine or alcohol by carbon dioxide 中国科学院兰州化学物理研究所 2022-05-20 CN disclosed
CN-112851538-A Method for promoting acylation of amine or alcohol by carbon dioxide 中国科学院兰州化学物理研究所 2021-05-28 CN disclosed
CN-105884699-B 4- substituted aniline quinazoline derivative and its preparation method and application 中国药科大学 2019-05-07 CN disclosed
CN-107459480-A A kind of substituted bisarylurea histon deacetylase (HDAC) inhibitor 镇江斯格派医疗器械有限公司 2017-12-12 CN disclosed
CN-105884699-A 4-substituted anilinoquinazoline derivatives, and preparation method and application thereof 中国药科大学 2016-08-24 CN disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110269758-A1 NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS MERCK PATENT GMBH (DE) 2011-11-03 US disclosed
US-6197803-B1 VIRICIDES; PREVENTION REPRODUCTION AMERICAN HOME PRODUCTS CORPORATION 2001-03-06 US disclosed
US-6166028-A Diaminopuridine-containing thiourea inhibitors of herpes viruses AMERICAN HOME PRODUCTS CORPORATION (US) 2000-12-26 US disclosed
WO-2000034238-A1 THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034261-A2 HETEROCYCLIC CARBOXAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A SUBSTITUTED PHENYLENEDIAMINE GROUP AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034260-A2 ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034268-A1 THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034269-A1 THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034237-A2 ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269758-A1 NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS AURKA, AURKC, AURKB KMT2A 1060/4885MEN1 1490/4885POLB 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.